Is TDAC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Translational Development Acquisition Corp. Ordinary Shares has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the TDAC stock price target for 2026?

WallStSmart's 12-month price target for Translational Development Acquisition Corp. Ordinary Shares is $6.60.

TDAC

Translational Development Acquisition Corp. Ordinary Shares

NASDAQ: TDAC · FINANCIAL SERVICES · SHELL COMPANIES

$10.64

+0.09% today

Updated 2026-05-01

Market cap

$233.31M

P/E ratio

36.72

P/S ratio

—

EPS (TTM)

$0.29

Dividend yield

—

52W range

$10 – $11

Volume

0.0M

Market cap

$233.31M

P/E ratio

36.72

P/S ratio

—

EPS (TTM)

$0.29

Dividend yield

—

52W range

$10 – $11

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.5

Profitability

4.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

$6.60

-37.97%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $7.99M — positive

Risks

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	—	$0.00	$0.00	$0.00	$-553290.00
Net income	$-70662.00	$-485550.00	$-71012.00	$6.36M	$1.60M
EPS	—	—	—	—	$0.29
Free cash flow	$-97168.00	$-204.00	$-851450.00	$-608390.00	$7.99M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TDAC	$233.31M	30	4.3	3.5	4.7	5.0	—	Avoid
BRK-B	$1.03T	54	3.3	7.5	5.0	8.0	—	Buy
BRK-A	$1.02T	51	3.3	7.5	5.0	8.0	—	Buy
JPM	$828.64B	73	8.0	8.0	5.7	5.5	—	Strong Buy
V	$636.99B	68	7.3	10.0	5.0	5.5	—	Strong Buy
MA	$444.77B	70	8.0	10.0	4.3	6.0	—	Strong Buy

Smart narrative

Translational Development Acquisition Corp. Ordinary Shares trades at $10.64. representing a P/E of 36.72x trailing earnings. Our Smart Value Score of 30/100 indicates the stock is weak.

Frequently asked questions

What is Translational Development Acquisition Corp. Ordinary Shares's stock price?

Translational Development Acquisition Corp. Ordinary Shares (TDAC) trades at $10.64.

Is Translational Development Acquisition Corp. Ordinary Shares overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Translational Development Acquisition Corp. Ordinary Shares (TDAC)?

The analyst target price is $—, representing NaN% downside from the current price of $10.64.

Company info

SectorFINANCIAL SERVICES

IndustrySHELL COMPANIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE—

Beta—

50D MA$10.58

200D MA$10.45

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TDAC vs BRK-B →TDAC vs BRK-A →TDAC vs JPM →Stock screener →